Pinterest IPO Plans Shift Into High Gear With Filing

Pinterest on Friday filed for an initial public offering with the Securities and Exchange Commission, following a number of other major companies forging ahead with plans to go public.

Also filing with the SEC on Friday for its IPO is Zoom, a provider of video conferencing software and services.

Pinterest filed its S-1 prospectus with the SEC, which shows that revenue in 2018 reached $755.9 million, up 60% from the year-ago period, with a net loss of $63 million. It ended the year with 265 million monthly active users, up from 250 million in September.

The Pinterest IPO filing said it seeks to […] Read more

Lawyer fined for impersonating wife in divorce case

Woman returned wedding ring to husband / Shutterstock

A Surrey lawyer has been fined more than $11,000 for impersonating a woman in a divorce case while obtaining a credit report for the husband.

The March 19 decision by the Law Society of British Columbia said lawyer Kevin J. Groves, acting for the husband (called only JR in the decision) in January 2017, asked if the man wanted a credit report on his wife (called NR) as confirmation of financial information provided in the divorce proceedings.

JR agreed and Groves logged onto the Equifax credit reporting service.

With the husband’s help, Groves “completed a request […] Read more

HCI Group, Inc. (HCI) Reaches $41.74 After 4.00% Up Move; Equifax (EFX) Has 0.7 Sentiment

The stock of HCI Group, Inc. (NYSE:HCI) is a huge mover today! The stock increased 1.09% or $0.45 during the last trading session, reaching $41.74. About 204,677 shares traded or 217.35% up from the average. HCI Group, Inc. (NYSE:HCI) has risen 27.03% since March 22, 2018 and is uptrending. It has outperformed by 22.66% the S&P500. Some Historical HCI News: 23/03/2018 – TEVA PHARMACEUTICAL INDUSTRIES – ANNOUNCED LAUNCH OF GENERIC VERSION OF ALOXI (PALONOSETRON HCI) INJECTION, 0.25 MG/5 ML, IN THE UNITED STATES; 06/03/2018 Sunovion Receives FDA Approval of Supplemental New Drug Application (sNDA) for Use of Latuda® (lurasidone HCI) […] Read more

Columbus Hill Capital Management LP Has Decreased Equifax (EFX) Position By $3.49 Million; 4 Analysts Are Bullish The Coca-Cola Company (KO) Last Week – The Financial Examiner

Among 10 analysts covering Coca-Cola (NYSE:KO), 4 have Buy rating, 0 Sell and 6 Hold. Therefore 40% are positive. Coca-Cola had 13 analyst reports since October 31, 2018 according to SRatingsIntel. The firm earned “Buy” rating on Friday, March 8 by Wells Fargo. The company was maintained on Friday, March 8 by Jefferies. Deutsche Bank maintained The Coca-Cola Company (NYSE:KO) on Wednesday, October 31 with “Buy” rating. The stock has “Neutral” rating by Citigroup on Friday, February 15. The stock of The Coca-Cola Company (NYSE:KO) earned “Hold” rating by HSBC on Tuesday, March 12. The stock of The Coca-Cola Company […] Read more

6 Key Tips to Keep in Mind

Experts share the prime window for detecting intruders, when to contact law enforcement, and what they wish they did differently after a breach.

1 of 7

(Image: Jcomp stock.adobe.com)

Most data breaches we see in the headlines are the biggest – but a security incident doesn’t need to be of Equifax proportions to bring down a company. Impact is relative to business size.

“The vast majority of breaches are small [and] don’t get much attention,” said Suzanne Widup, senior analyst at Verizon Enterprise Solutions, during a talk at the recent RSA Conference in San Francisco. “The impact is going to […] Read more

Biogen Stock Slips As It Unveils New Test In Alzheimer’s Treatment

Biogen (BIIB) and Japan’s Eisai announced a new study in Alzheimer’s treatment Friday following a high-profile failure this week that sent Biogen stock into a tailspin.

X

In morning action on today’s stock market, Biogen stock slipped 3.1%, near 219.90, in high volume. On Thursday, Biogen and Eisai terminated two studies of a drug called aducanumab in Alzheimer’s treatment after a committee said it would likely fail.

Aducanumab targeted a problematic plaque in the brain known as beta amyloid. On Thursday, one analyst said the beta amyloid theory of Alzheimer’s treatment is “dead.” Leerink analyst Geoffrey Porges, on Friday, called for Biogen to […] Read more

Stock Market Dives After Weak Data In Europe

The U.S. stock market gave up some ground late Friday morning but stayed on track for gains for the week. Meanwhile, President Donald Trump said in a Fox Business Network interview aired Friday that a final agreement with China on trade “will probably happen.”

X

Trump, though, fired some fresh trade shots on another front, saying the European Union “treats us as badly as China” does. Other news in Europe was bearish. Manufacturing in Germany contracted for a third month in a row, and the Eurozone PMI gauge fell short of estimates.

The Euro Stoxx 50, an index of Eurozone stocks, dropped 1.6%, […] Read more

MongoDB Stock Gets Top Rating With New Coverage

MongoDB stock got a rating of outperform as a Wall Street analyst initiated coverage on the database software company Friday, but shares fell along with the market.

X

MongoDB (MDB) is disrupting the $30 billion operational database software market, which has seen little innovation for decades, William Blair analyst Jason Ader said in a note to clients.

“The main drivers of disruption have been cloud computing and open-source software — which together have revolutionized how applications are built, where they are located, and how they interact with their underlying data,” Adler wrote.

MongoDB has an open-source software strategy with a software-as-a-service business model. It […] Read more

Lumentum Stock Upgraded, Analyst Says Worst Over For Apple Worries

JPMorgan upgraded Lumentum Holdings (LITE) Friday on views that Apple (AAPL)-related worries should ease while demand for optical devices built into telecom networks will pick up. Lumentum stock gained in early trading as the Nasdaq Composite fell.

X

Samik Chatterjee, a JPMorgan analyst, upgraded Lumentum stock to overweight. He raised Lumentum’s price target to 65 from 50.

One driver of the Lumentum stock upgrade is a “solid outlook for the telecom business on the back of strong growth led by 5G wireless investments,” Chatterjee said in a report to clients.

The JPMorgan analyst also expects “upside to synergy targets relative to the recent acquisition […] Read more